"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain.

"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain.

BACKGROUND:Two-drug regimens (2DR) to treat HIV infection have the potential to reduce long-term toxicity and increase therapeutic options for people living with HIV (PLHIV). Prior phase III trials, SWORD-1 and SWORD-2, as well as GEMINI-1 and GEMINI-2, have demonstrated that a dolutegravir-based 2D...

Full description

Bibliographic Details
Main Authors: Wendy Davis, Andrea Mantsios, Tahilin Karver, Miranda Murray, Yogesh Punekar, Douglas Ward, U Fritz Bredeek, Santiago Moreno, Dolores Merino, Hernando Knobel, Antonio Campis, Deanna Kerrigan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0232473

Similar Items

Similar Items